Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2129 - 2136 of 11456 results
The Shrinking Scope of Confidentiality: California Extends Confidentiality Ban to All FEHA Protected Classes
December 15, 2021| Blog| Viewpoint
Vaccinated or Not - California’s Indoor Mask Mandate Resumes
December 15, 2021| Blog| Viewpoint
California Court Deals Blow to Employee Mobility
December 14, 2021| Blog| Viewpoint
CRITICAL ALERT: Log4Shell
December 13, 2021| Alert| Viewpoint
2021 Pro Bono Journal - Transcending
December 13, 2021| Article| Viewpoint
DOJ and FTC Virtual Workshop: Agencies Discuss Whole-of-Government Approach and New Solutions to Address Competition Issues in Labor Markets
December 10, 2021| Blog| Viewpoint
MintzTech Connect Industry News: Spotlight on Miyoko’s Creamery
December 10, 2021| Article| Viewpoint
MintzTech Connect: All Things Technology — December 2021
December 10, 2021| Article| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.